Selected research
Market Structure
Global Gynecological Contraceptive Implant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gynecological Contraceptive Implant market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Gynecological Contraceptive Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gynecological Contraceptive Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gynecological Contraceptive Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gynecological Contraceptive Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gynecological Contraceptive Implant include CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences and Mona Lisa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Gynecological Contraceptive Implant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gynecological Contraceptive Implant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gynecological Contraceptive Implant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gynecological Contraceptive Implant market size, projected growth trends, production technologies, key applications, and end-use industries.
Gynecological Contraceptive Implant Segment by Company
CooperSurgical
Egemen International
ERENLER MEDIKAL
Gyneas
Laboratoire CCD
Medical Engineering Corporation
Melbea
Meril Life Sciences
Mona Lisa
Pregna
Pregna International
Prosan International
Rongbo Medical
SMB Corporation of India
AbbVie
Bayer
Gynecological Contraceptive Implant Segment by Type
Non-biodegradable
Biodegradable
Gynecological Contraceptive Implant Segment by Application
Subcutaneously
Uterus
Gynecological Contraceptive Implant Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gynecological Contraceptive Implant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gynecological Contraceptive Implant and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gynecological Contraceptive Implant.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gynecological Contraceptive Implant market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gynecological Contraceptive Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gynecological Contraceptive Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Gynecological Contraceptive Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Non-biodegradable
- Biodegradable
Applications
- Subcutaneously
- Uterus
Companies covered
- CooperSurgical
- Egemen International
- ERENLER MEDIKAL
- Gyneas
- Laboratoire CCD
- Medical Engineering Corporation
- Melbea
- Meril Life Sciences
- Mona Lisa
- Pregna
- Pregna International
- Prosan International
- Rongbo Medical
- SMB Corporation of India
- AbbVie
- Bayer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gynecological Contraceptive Implant Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gynecological Contraceptive Implant Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Gynecological Contraceptive Implant Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Gynecological Contraceptive Implant Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Gynecological Contraceptive Implant Market Dynamics
- 2.1 Gynecological Contraceptive Implant Industry Trends
- 2.2 Gynecological Contraceptive Implant Industry Drivers
- 2.3 Gynecological Contraceptive Implant Industry Opportunities and Challenges
- 2.4 Gynecological Contraceptive Implant Industry Restraints
3 Gynecological Contraceptive Implant Market by Manufacturers
- 3.1 Global Gynecological Contraceptive Implant Revenue by Manufacturers (2021-2026)
- 3.2 Global Gynecological Contraceptive Implant Sales by Manufacturers (2021-2026)
- 3.3 Global Gynecological Contraceptive Implant Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Gynecological Contraceptive Implant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gynecological Contraceptive Implant Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Gynecological Contraceptive Implant Manufacturers, Product Type & Application
- 3.7 Global Gynecological Contraceptive Implant Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gynecological Contraceptive Implant Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gynecological Contraceptive Implant Players Market Share by Revenue in 2025
- 3.8.3 2025 Gynecological Contraceptive Implant Tier 1, Tier 2, and Tier 3
4 Gynecological Contraceptive Implant Market by Type
- 4.1 Gynecological Contraceptive Implant Type Introduction
- 4.1.1 Non-biodegradable
- 4.1.2 Biodegradable
- 4.2 Global Gynecological Contraceptive Implant Sales by Type
- 4.2.1 Global Gynecological Contraceptive Implant Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gynecological Contraceptive Implant Sales by Type (2021-2032)
- 4.2.3 Global Gynecological Contraceptive Implant Sales Market Share by Type (2021-2032)
- 4.3 Global Gynecological Contraceptive Implant Revenue by Type
- 4.3.1 Global Gynecological Contraceptive Implant Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Gynecological Contraceptive Implant Revenue by Type (2021-2032)
- 4.3.3 Global Gynecological Contraceptive Implant Revenue Market Share by Type (2021-2032)
5 Gynecological Contraceptive Implant Market by Application
- 5.1 Gynecological Contraceptive Implant Application Introduction
- 5.1.1 Subcutaneously
- 5.1.2 Uterus
- 5.2 Global Gynecological Contraceptive Implant Sales by Application
- 5.2.1 Global Gynecological Contraceptive Implant Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gynecological Contraceptive Implant Sales by Application (2021-2032)
- 5.2.3 Global Gynecological Contraceptive Implant Sales Market Share by Application (2021-2032)
- 5.3 Global Gynecological Contraceptive Implant Revenue by Application
- 5.3.1 Global Gynecological Contraceptive Implant Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Gynecological Contraceptive Implant Revenue by Application (2021-2032)
- 5.3.3 Global Gynecological Contraceptive Implant Revenue Market Share by Application (2021-2032)
6 Global Gynecological Contraceptive Implant Sales by Region
- 6.1 Global Gynecological Contraceptive Implant Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gynecological Contraceptive Implant Sales by Region (2021-2032)
- 6.2.1 Global Gynecological Contraceptive Implant Sales by Region (2021-2026)
- 6.2.2 Global Gynecological Contraceptive Implant Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gynecological Contraceptive Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Gynecological Contraceptive Implant Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Gynecological Contraceptive Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Gynecological Contraceptive Implant Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Gynecological Contraceptive Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Gynecological Contraceptive Implant Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Gynecological Contraceptive Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Gynecological Contraceptive Implant Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Gynecological Contraceptive Implant Revenue by Region
- 7.1 Global Gynecological Contraceptive Implant Revenue by Region
- 7.1.1 Global Gynecological Contraceptive Implant Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Gynecological Contraceptive Implant Revenue by Region (2021-2026)
- 7.1.3 Global Gynecological Contraceptive Implant Revenue by Region (2027-2032)
- 7.1.4 Global Gynecological Contraceptive Implant Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Gynecological Contraceptive Implant Revenue (2021-2032)
- 7.2.2 North America Gynecological Contraceptive Implant Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Gynecological Contraceptive Implant Revenue (2021-2032)
- 7.3.2 Europe Gynecological Contraceptive Implant Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Gynecological Contraceptive Implant Revenue (2021-2032)
- 7.4.2 Asia-Pacific Gynecological Contraceptive Implant Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Gynecological Contraceptive Implant Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Gynecological Contraceptive Implant Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 CooperSurgical
- 8.1.1 CooperSurgical Company Information
- 8.1.2 CooperSurgical Business Overview
- 8.1.3 CooperSurgical Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 CooperSurgical Gynecological Contraceptive Implant Product Portfolio
- 8.1.5 CooperSurgical Recent Developments
- 8.2 Egemen International
- 8.2.1 Egemen International Company Information
- 8.2.2 Egemen International Business Overview
- 8.2.3 Egemen International Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Egemen International Gynecological Contraceptive Implant Product Portfolio
- 8.2.5 Egemen International Recent Developments
- 8.3 ERENLER MEDIKAL
- 8.3.1 ERENLER MEDIKAL Company Information
- 8.3.2 ERENLER MEDIKAL Business Overview
- 8.3.3 ERENLER MEDIKAL Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 ERENLER MEDIKAL Gynecological Contraceptive Implant Product Portfolio
- 8.3.5 ERENLER MEDIKAL Recent Developments
- 8.4 Gyneas
- 8.4.1 Gyneas Company Information
- 8.4.2 Gyneas Business Overview
- 8.4.3 Gyneas Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Gyneas Gynecological Contraceptive Implant Product Portfolio
- 8.4.5 Gyneas Recent Developments
- 8.5 Laboratoire CCD
- 8.5.1 Laboratoire CCD Company Information
- 8.5.2 Laboratoire CCD Business Overview
- 8.5.3 Laboratoire CCD Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Laboratoire CCD Gynecological Contraceptive Implant Product Portfolio
- 8.5.5 Laboratoire CCD Recent Developments
- 8.6 Medical Engineering Corporation
- 8.6.1 Medical Engineering Corporation Company Information
- 8.6.2 Medical Engineering Corporation Business Overview
- 8.6.3 Medical Engineering Corporation Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Medical Engineering Corporation Gynecological Contraceptive Implant Product Portfolio
- 8.6.5 Medical Engineering Corporation Recent Developments
- 8.7 Melbea
- 8.7.1 Melbea Company Information
- 8.7.2 Melbea Business Overview
- 8.7.3 Melbea Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Melbea Gynecological Contraceptive Implant Product Portfolio
- 8.7.5 Melbea Recent Developments
- 8.8 Meril Life Sciences
- 8.8.1 Meril Life Sciences Company Information
- 8.8.2 Meril Life Sciences Business Overview
- 8.8.3 Meril Life Sciences Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Meril Life Sciences Gynecological Contraceptive Implant Product Portfolio
- 8.8.5 Meril Life Sciences Recent Developments
- 8.9 Mona Lisa
- 8.9.1 Mona Lisa Company Information
- 8.9.2 Mona Lisa Business Overview
- 8.9.3 Mona Lisa Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Mona Lisa Gynecological Contraceptive Implant Product Portfolio
- 8.9.5 Mona Lisa Recent Developments
- 8.10 Pregna
- 8.10.1 Pregna Company Information
- 8.10.2 Pregna Business Overview
- 8.10.3 Pregna Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Pregna Gynecological Contraceptive Implant Product Portfolio
- 8.10.5 Pregna Recent Developments
- 8.11 Pregna International
- 8.11.1 Pregna International Company Information
- 8.11.2 Pregna International Business Overview
- 8.11.3 Pregna International Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Pregna International Gynecological Contraceptive Implant Product Portfolio
- 8.11.5 Pregna International Recent Developments
- 8.12 Prosan International
- 8.12.1 Prosan International Company Information
- 8.12.2 Prosan International Business Overview
- 8.12.3 Prosan International Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Prosan International Gynecological Contraceptive Implant Product Portfolio
- 8.12.5 Prosan International Recent Developments
- 8.13 Rongbo Medical
- 8.13.1 Rongbo Medical Company Information
- 8.13.2 Rongbo Medical Business Overview
- 8.13.3 Rongbo Medical Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Rongbo Medical Gynecological Contraceptive Implant Product Portfolio
- 8.13.5 Rongbo Medical Recent Developments
- 8.14 SMB Corporation of India
- 8.14.1 SMB Corporation of India Company Information
- 8.14.2 SMB Corporation of India Business Overview
- 8.14.3 SMB Corporation of India Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 SMB Corporation of India Gynecological Contraceptive Implant Product Portfolio
- 8.14.5 SMB Corporation of India Recent Developments
- 8.15 AbbVie
- 8.15.1 AbbVie Company Information
- 8.15.2 AbbVie Business Overview
- 8.15.3 AbbVie Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 AbbVie Gynecological Contraceptive Implant Product Portfolio
- 8.15.5 AbbVie Recent Developments
- 8.16 Bayer
- 8.16.1 Bayer Company Information
- 8.16.2 Bayer Business Overview
- 8.16.3 Bayer Gynecological Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Bayer Gynecological Contraceptive Implant Product Portfolio
- 8.16.5 Bayer Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Gynecological Contraceptive Implant Value Chain Analysis
- 9.1.1 Gynecological Contraceptive Implant Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gynecological Contraceptive Implant Production Mode & Process
- 9.2 Gynecological Contraceptive Implant Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gynecological Contraceptive Implant Distributors
- 9.2.3 Gynecological Contraceptive Implant Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst